The Elusive Horizon: Biomarkers in Urothelial Carcinoma.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 38278663.
- Also identified by DOI 10.1016/j.eururo.2024.01.004.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Urinary tests for circulating tumor DNA have potential for accurate discrimination of bladder cancer from other common inflammatory processes. Efforts are still needed to determine whether these tests can differentiate between cancer and field cancerization and to demonstrate clinical benefit in prospective trials.
Medical subject headings
- Urinary Bladder Neoplasms
- Carcinoma, Transitional Cell
- Circulating Tumor DNA